Literature DB >> 28717813

Cut-off Points for Muscle Mass - Not Grip Strength or Gait Speed - Determine Variations in Sarcopenia Prevalence.

F Masanés1, X Rojano I Luque, A Salvà, J A Serra-Rexach, I Artaza, F Formiga, F Cuesta, A López Soto, D Ruiz, A J Cruz-Jentoft.   

Abstract

OBJECTIVES: The European Working Group on Sarcopenia in Older People (EWGSOP) has proposed different methods and cut-off points for the three parameters that define sarcopenia: muscle mass, muscle strength and physical performance. Although this facilitates clinical practice, it limits comparability between studies and leads to wide differences in published prevalence rates. The aim of this study was to assess how changes in cut-off points for muscle mass, gait speed and grip strength affected sarcopenia prevalence according to EWGSOP criteria.
METHODS: Cross-sectional analysis of elderly individuals recruited from outpatient clinics (n=298) and nursing homes (n=276). We measured muscle mass, grip strength and gait speed and assessed how changes in cut-off points changed sarcopenia prevalence in both populations.
RESULTS: An increase from 5.45 kg/m2 to 6.68 kg/m2 in the muscle mass index for female outpatients and nursing-home residents increased sarcopenia prevalence from 4% to 23% and from 9% to 47%, respectively; for men, for an increase from 7.25 kg/m2 to 8.87 kg/m2, the corresponding increases were from 1% to 22% and from 6% to 41%, respectively. Changes in gait speed and grip strength had a limited impact on sarcopenia prevalence.
CONCLUSION: The cut-off points used for muscle mass affect the reported prevalence rates for sarcopenia and, in turn, affect comparability between studies. The main factors influencing the magnitude of the change are muscle mass index distribution in the population and the absolute value of the cut-off points: the same difference between two references (e.g., 7.5 kg/m2 to 7.75 kg/m2 or 7.75 kg/m2 to 8 kg/m2) may produce different changes in prevalence. Changes in cut-off points for gait speed and grip strength had a limited impact on sarcopenia prevalence and on study comparability.

Entities:  

Keywords:  Sarcopenia; comparability; epidemiology; performance; screening

Mesh:

Year:  2017        PMID: 28717813     DOI: 10.1007/s12603-016-0844-5

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


  23 in total

1.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

2.  Prevalence and risk factors of sarcopenia among nursing home older residents.

Authors:  Francesco Landi; Rosa Liperoti; Domenico Fusco; Simona Mastropaolo; Davide Quattrociocchi; Anna Proia; Andrea Russo; Roberto Bernabei; Graziano Onder
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-03-10       Impact factor: 6.053

3.  Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.

Authors:  Alfonso J Cruz-Jentoft; Jean Pierre Baeyens; Jürgen M Bauer; Yves Boirie; Tommy Cederholm; Francesco Landi; Finbarr C Martin; Jean-Pierre Michel; Yves Rolland; Stéphane M Schneider; Eva Topinková; Maurits Vandewoude; Mauro Zamboni
Journal:  Age Ageing       Date:  2010-04-13       Impact factor: 10.668

4.  Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women.

Authors:  Ian Janssen; Richard N Baumgartner; Robert Ross; Irwin H Rosenberg; Ronenn Roubenoff
Journal:  Am J Epidemiol       Date:  2004-02-15       Impact factor: 4.897

5.  Screening for Malnutrition in Community Dwelling Older Japanese: Preliminary Development and Evaluation of the Japanese Nutritional Risk Screening Tool (NRST).

Authors:  N C Htun; K Ishikawa-Takata; A Kuroda; T Tanaka; T Kikutani; S P Obuchi; H Hirano; K Iijima
Journal:  J Nutr Health Aging       Date:  2016-02       Impact factor: 4.075

6.  The Impact of Different Diagnostic Criteria on the Prevalence of Sarcopenia in Healthy Elderly Participants and Geriatric Outpatients.

Authors:  Esmee M Reijnierse; Marijke C Trappenburg; Morena J Leter; Gerard Jan Blauw; Sarianna Sipilä; Elina Sillanpää; Marco V Narici; Jean-Yves Hogrel; Gillian Butler-Browne; Jamie S McPhee; Helena Gapeyeva; Mati Pääsuke; Marian A E de van der Schueren; Carel G M Meskers; Andrea B Maier
Journal:  Gerontology       Date:  2015-04-02       Impact factor: 5.140

7.  Defining sarcopenia: the impact of different diagnostic criteria on the prevalence of sarcopenia in a large middle aged cohort.

Authors:  A Y Bijlsma; C G M Meskers; C H Y Ling; M Narici; S E Kurrle; I D Cameron; R G J Westendorp; A B Maier
Journal:  Age (Dordr)       Date:  2013-06

8.  Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the National Institutes of Health (FNIH) sarcopenia project.

Authors:  Robert R McLean; Michelle D Shardell; Dawn E Alley; Peggy M Cawthon; Maren S Fragala; Tamara B Harris; Anne M Kenny; Katherine W Peters; Luigi Ferrucci; Jack M Guralnik; Stephen B Kritchevsky; Douglas P Kiel; Maria T Vassileva; Qian-Li Xue; Subashan Perera; Stephanie A Studenski; Thuy-Tien L Dam
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-05       Impact factor: 6.053

9.  Grip strength cutpoints for the identification of clinically relevant weakness.

Authors:  Dawn E Alley; Michelle D Shardell; Katherine W Peters; Robert R McLean; Thuy-Tien L Dam; Anne M Kenny; Maren S Fragala; Tamara B Harris; Douglas P Kiel; Jack M Guralnik; Luigi Ferrucci; Stephen B Kritchevsky; Stephanie A Studenski; Maria T Vassileva; Peggy M Cawthon
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-05       Impact factor: 6.053

Review 10.  Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS).

Authors:  Alfonso J Cruz-Jentoft; Francesco Landi; Stéphane M Schneider; Clemente Zúñiga; Hidenori Arai; Yves Boirie; Liang-Kung Chen; Roger A Fielding; Finbarr C Martin; Jean-Pierre Michel; Cornel Sieber; Jeffrey R Stout; Stephanie A Studenski; Bruno Vellas; Jean Woo; Mauro Zamboni; Tommy Cederholm
Journal:  Age Ageing       Date:  2014-09-21       Impact factor: 10.668

View more
  21 in total

1.  Prevalence and Diagnosis of Sarcopenia in Residential Facilities: A Systematic Review.

Authors:  Ana Isabel Rodríguez-Rejón; María Dolores Ruiz-López; Carmina Wanden-Berghe; Reyes Artacho
Journal:  Adv Nutr       Date:  2019-01-01       Impact factor: 8.701

2.  Editorial: Weight Loss is a Major Cause of Frailty.

Authors:  B Fougère; J E Morley
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

3.  Diagnosis of Sarcopenia in Long-Term Care Homes for the Elderly: the Sensitivity and Specificity of Two Simplified Algorithms with Respect to the EWGSOP Consensus.

Authors:  A I Rodriguez-Rejon; R Artacho; A Puerta; A Zuñiga; M D Ruiz-Lopez
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

4.  Systematic review and meta-analysis of prevalence of sarcopenia in post acute inpatient rehabilitation.

Authors:  I Churilov; L Churilov; R J MacIsaac; E I Ekinci
Journal:  Osteoporos Int       Date:  2018-02-18       Impact factor: 4.507

5.  Skeletal muscle index is an independent predictor of early recurrence in non-obese colon cancer patients.

Authors:  Dagmar Schaffler-Schaden; Christof Mittermair; Theresa Birsak; Michael Weiss; Tobias Hell; Gottfried Schaffler; Helmut Weiss
Journal:  Langenbecks Arch Surg       Date:  2020-06-05       Impact factor: 3.445

6.  Sarcopenia: revised European consensus on definition and diagnosis.

Authors:  Alfonso J Cruz-Jentoft; Gülistan Bahat; Jürgen Bauer; Yves Boirie; Olivier Bruyère; Tommy Cederholm; Cyrus Cooper; Francesco Landi; Yves Rolland; Avan Aihie Sayer; Stéphane M Schneider; Cornel C Sieber; Eva Topinkova; Maurits Vandewoude; Marjolein Visser; Mauro Zamboni
Journal:  Age Ageing       Date:  2019-01-01       Impact factor: 10.668

7.  Sarcopenia in Neurological Patients: Standard Values for Temporal Muscle Thickness and Muscle Strength Evaluation.

Authors:  Ariane Steindl; Johannes Leitner; Matthias Schwarz; Karl-Heinz Nenning; Ulrika Asenbaum; Sophie Mayer; Ramona Woitek; Michael Weber; Veronika Schöpf; Anna S Berghoff; Thomas Berger; Georg Widhalm; Daniela Prayer; Matthias Preusser; Julia Furtner
Journal:  J Clin Med       Date:  2020-04-28       Impact factor: 4.241

8.  Rapid Geriatric Assessment Using Mobile App in Primary Care: Prevalence of Geriatric Syndromes and Review of Its Feasibility.

Authors:  Reshma Aziz Merchant; Richard Jor Yeong Hui; Sing Cheer Kwek; Meena Sundram; Arthur Tay; Jerome Jayasundram; Matthew Zhixuan Chen; Shu Ee Ng; Li Feng Tan; John E Morley
Journal:  Front Med (Lausanne)       Date:  2020-07-08

9.  Sarcopenia: Influence of Regional Skeletal Muscle Cutoff Points and Fat-Free Mass in Older Mexican People-A Pilot Study.

Authors:  Heliodoro Alemán-Mateo; Miriam T López-Teros; Roxana E Ruiz-Valenzuela; Maribel Ramírez-Torres; René Urquidez-Romero
Journal:  Curr Gerontol Geriatr Res       Date:  2020-05-31

10.  Effects of Leucine Administration in Sarcopenia: A Randomized and Placebo-controlled Clinical Trial.

Authors:  Francisco M Martínez-Arnau; Rosa Fonfría-Vivas; Cristina Buigues; Yolanda Castillo; Pilar Molina; Aldert J Hoogland; Femke van Doesburg; Leo Pruimboom; Julio Fernández-Garrido; Omar Cauli
Journal:  Nutrients       Date:  2020-03-27       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.